GlaxoSmithKline GmbH & Co. KG
Head Finance Business Partner Oncology(m/w/x)
Full-timeWith HomeofficeSenior
München
New Job?Nejo!
Your personal AI career agent
GLGlaxoSmithKline GmbH & Co. KG
Head Finance Business Partner New Product Launches(m/w/x)
München
Full-timeWith Home OfficeSenior
AI/ML
Data Science
Nejo AI Summary
Forecasting early assets and P&Ls for new biopharma products. Financial modelling and scenario planning experience required. Early asset valuation and investment analysis.
Requirements
- Finance or business degree, or professional qualification (e.g. ACA, CIMA, ACCA, CPA, MBA)
- Financial modelling, scenario planning, investment appraisal experience
- Financial planning/forecasting understanding
- Understanding of financial systems and processes (CERPS, Bison, CF/CCC, VISTA)
- Translating data into strategic recommendations
- Embedding data-driven decision-making behaviours
- Breadth of experience across business areas
- Enterprise level perspective
- Influencing and shaping senior leadership decisions
- Challenging constructively across stakeholders
- Operating effectively with senior stakeholders
- Complex, cross-functional, matrix environments experience
- Leading and driving change
- Fast-moving, ambiguous environments experience
- Competing priorities management
- Risk management skills
- Process improvement skills
- Project management skills
- Pharmaceutical industry experience
- Highly regulated environments experience
- Leading digital transformation (finance/commercial)
- Automation experience
- AI-enabled insights experience
- Advanced analytics platforms adoption (e.g., MMM, Genie)
Tasks
- Own decision-grade Forecast Valuation and bottom-up P&Ls for Early assets
- Conduct optimal resource and investment analysis
- Build base, upside, and downside scenarios for governance and EU planning
- Define and challenge epidemiology, uptake, price, and supply assumptions
- Maintain transparent and comprehensive scenario plans and R&O registers
- Contribute to L-24 and L-18 bottom-up submissions
- Support handshakes with Access, Medical, and Supply for LRR decision readiness
- Translate forecast outcomes into clear investment asks and resourcing options
- Enable timely activation decisions and first-time-right LRR outcomes
- Integrate early-asset assumptions into the DRM
- Reconcile value-to-volume and track a 3-10 year horizon
- Provide crisp variance narratives and mitigation plans
- Standardize cross-BU methodology for DE outputs
- Partner with Market Access to pressure-test price corridors
- Run sensitivity analyses across access scenarios
- Prepare evidence-based recommendations for pricing approval forums
- Model investment options for medical, access, promo, and field activities
- Quantify returns to inform prioritization across assets and milestones
- Lead structured what-if scenarios on timing, label, access, and capacity
- Articulate implications for EU scale-up and Plan
- Identify margin levers and SG&A guardrails for launch phases
- Embed actions into DRM/MPR follow-up
- Leverage AI forecasting roadmap for NPIs and tenders
- Codify overlays and continuously tune with Demand/Supply
- Use Genie, MMM insights, and other enterprise data products
- Refine assumptions and spot opportunities
- Accelerate analytics and promote good practice across Finance and Commercial
Work Experience
- 5 years
Education
- Bachelor's degree
Languages
- English – Business Fluent
Tools & Technologies
- CERPS
- Bison
- CF/CCC
- VISTA
- MMM
- Genie
Find the original job posting in its most current version here. Nejo automatically captured this job from the website of GlaxoSmithKline GmbH & Co. KG and processed the information on Nejo with the help of AI for you. Despite careful analysis, some information may be incomplete or inaccurate. Please always verify all details in the original posting! Content and copyrights of the original posting belong to the advertising company.
Like this job?
BetaYour Career Agent finds similar jobs for you every day.
Not a perfect match?
- Regeneron GmbH
Finance Business Partner - Associate Director(m/w/x)
Full-timeWith HomeofficeManagementMünchen - Maltego
Director of FP&A(m/w/x)
Full-timeWith HomeofficeSeniorMünchen - Gilead Sciences
Procurement Business Partner(m/w/x)
Full-timeWith HomeofficeExperiencedMünchen
GLGlaxoSmithKline GmbH & Co. KG
Head Finance Business Partner New Product Launches(m/w/x)
München
Full-timeWith Home OfficeSenior
AI/ML
Data Science
Nejo AI Summary
Forecasting early assets and P&Ls for new biopharma products. Financial modelling and scenario planning experience required. Early asset valuation and investment analysis.
Requirements
- Finance or business degree, or professional qualification (e.g. ACA, CIMA, ACCA, CPA, MBA)
- Financial modelling, scenario planning, investment appraisal experience
- Financial planning/forecasting understanding
- Understanding of financial systems and processes (CERPS, Bison, CF/CCC, VISTA)
- Translating data into strategic recommendations
- Embedding data-driven decision-making behaviours
- Breadth of experience across business areas
- Enterprise level perspective
- Influencing and shaping senior leadership decisions
- Challenging constructively across stakeholders
- Operating effectively with senior stakeholders
- Complex, cross-functional, matrix environments experience
- Leading and driving change
- Fast-moving, ambiguous environments experience
- Competing priorities management
- Risk management skills
- Process improvement skills
- Project management skills
- Pharmaceutical industry experience
- Highly regulated environments experience
- Leading digital transformation (finance/commercial)
- Automation experience
- AI-enabled insights experience
- Advanced analytics platforms adoption (e.g., MMM, Genie)
Tasks
- Own decision-grade Forecast Valuation and bottom-up P&Ls for Early assets
- Conduct optimal resource and investment analysis
- Build base, upside, and downside scenarios for governance and EU planning
- Define and challenge epidemiology, uptake, price, and supply assumptions
- Maintain transparent and comprehensive scenario plans and R&O registers
- Contribute to L-24 and L-18 bottom-up submissions
- Support handshakes with Access, Medical, and Supply for LRR decision readiness
- Translate forecast outcomes into clear investment asks and resourcing options
- Enable timely activation decisions and first-time-right LRR outcomes
- Integrate early-asset assumptions into the DRM
- Reconcile value-to-volume and track a 3-10 year horizon
- Provide crisp variance narratives and mitigation plans
- Standardize cross-BU methodology for DE outputs
- Partner with Market Access to pressure-test price corridors
- Run sensitivity analyses across access scenarios
- Prepare evidence-based recommendations for pricing approval forums
- Model investment options for medical, access, promo, and field activities
- Quantify returns to inform prioritization across assets and milestones
- Lead structured what-if scenarios on timing, label, access, and capacity
- Articulate implications for EU scale-up and Plan
- Identify margin levers and SG&A guardrails for launch phases
- Embed actions into DRM/MPR follow-up
- Leverage AI forecasting roadmap for NPIs and tenders
- Codify overlays and continuously tune with Demand/Supply
- Use Genie, MMM insights, and other enterprise data products
- Refine assumptions and spot opportunities
- Accelerate analytics and promote good practice across Finance and Commercial
Work Experience
- 5 years
Education
- Bachelor's degree
Languages
- English – Business Fluent
Tools & Technologies
- CERPS
- Bison
- CF/CCC
- VISTA
- MMM
- Genie
Find the original job posting in its most current version here. Nejo automatically captured this job from the website of GlaxoSmithKline GmbH & Co. KG and processed the information on Nejo with the help of AI for you. Despite careful analysis, some information may be incomplete or inaccurate. Please always verify all details in the original posting! Content and copyrights of the original posting belong to the advertising company.
Like this job?
BetaYour Career Agent finds similar jobs for you every day.
About the Company
GlaxoSmithKline GmbH & Co. KG
Industry
Pharmaceuticals
Description
GSK is a global biopharma company focused on innovative medicines and vaccines to improve health at scale.
Not a perfect match?
- GlaxoSmithKline GmbH & Co. KG
Head Finance Business Partner Oncology(m/w/x)
Full-timeWith HomeofficeSeniorMünchen - Regeneron GmbH
Finance Business Partner - Associate Director(m/w/x)
Full-timeWith HomeofficeManagementMünchen - Maltego
Director of FP&A(m/w/x)
Full-timeWith HomeofficeSeniorMünchen - Gilead Sciences
Procurement Business Partner(m/w/x)
Full-timeWith HomeofficeExperiencedMünchen